Russo P - Search Results

1

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.

Tang C, Xie AX, Liu EM, Kuo F, Kim M, DiNatale RG, Golkaram M, Chen YB, Gupta S, Motzer RJ, Russo P, Coleman J, Carlo MI, Voss MH, Kotecha RR, Lee CH, Tansey W, Schultz N, Hakimi AA, Reznik E. Tang C, et al. Among authors: russo p. Cell Metab. 2023 Aug 8;35(8):1424-1440.e5. doi: 10.1016/j.cmet.2023.06.005. Epub 2023 Jul 5. Cell Metab. 2023. PMID: 37413991 Free article.

2

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.

Motzer RJ, Gulati SC, Crown JP, Weisen S, Doherty M, Herr H, Fair W, Sheinfeld J, Sogani P, Russo P, et al. Motzer RJ, et al. Among authors: russo p. Cancer. 1992 Jan 15;69(2):550-6. doi: 10.1002/1097-0142(19920115)69:2<550::aid-cncr2820690245>3.0.co;2-d. Cancer. 1992. PMID: 1309436

3

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ. Motzer RJ, et al. Among authors: russo p. Cancer. 1991 Mar 1;67(5):1305-10. doi: 10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j. Cancer. 1991. PMID: 1703917 Clinical Trial.

4

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P, et al. Motzer RJ, et al. Among authors: russo p. Cancer. 1990 Dec 15;66(12):2476-81. doi: 10.1002/1097-0142(19901215)66:12<2476::aid-cncr2820661206>3.0.co;2-d. Cancer. 1990. PMID: 2174300 Clinical Trial.

5

Renal cell carcinoma.

Motzer RJ, Russo P, Nanus DM, Berg WJ. Motzer RJ, et al. Among authors: russo p. Curr Probl Cancer. 1997 Jul-Aug;21(4):185-232. doi: 10.1016/s0147-0272(97)80007-4. Curr Probl Cancer. 1997. PMID: 9285186 Free article. Review.

6

Systemic therapy for renal cell carcinoma.

Motzer RJ, Russo P. Motzer RJ, et al. Among authors: russo p. J Urol. 2000 Feb;163(2):408-17. J Urol. 2000. PMID: 10647643 Free article. Review.

7

Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma.

Motzer RJ, Mazumdar M, Bacik J, Russo P, Berg WJ, Metz EM. Motzer RJ, et al. Among authors: russo p. J Clin Oncol. 2000 May;18(9):1928-35. doi: 10.1200/JCO.2000.18.9.1928. J Clin Oncol. 2000. PMID: 10784634

8

A postoperative prognostic nomogram for renal cell carcinoma.

Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. Kattan MW, et al. Among authors: russo p. J Urol. 2001 Jul;166(1):63-7. J Urol. 2001. PMID: 11435824

9

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Motzer RJ, et al. Among authors: russo p. J Clin Oncol. 2002 Jan 1;20(1):289-96. doi: 10.1200/JCO.2002.20.1.289. J Clin Oncol. 2002. PMID: 11773181

10

Phase II trial of thalidomide for patients with advanced renal cell carcinoma.

Motzer RJ, Berg W, Ginsberg M, Russo P, Vuky J, Yu R, Bacik J, Mazumdar M. Motzer RJ, et al. Among authors: russo p. J Clin Oncol. 2002 Jan 1;20(1):302-6. doi: 10.1200/JCO.2002.20.1.302. J Clin Oncol. 2002. PMID: 11773183 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,196 results

Search Page